Where do OnKure Therapeutics, Inc.'s ratios come from?

Every ratio is computed from OnKure Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-74.4%—	——	——	——
Return on assets	-67.2%+2.7pp	-69.9%—	——	-39.6%-1.6pp
Liquidity
Current ratio	10.3×-0.5×	10.7×+6.1×	4.6×-10.3×	14.9×-9.9×
Quick ratio	10.3×-0.5×	10.7×+6.1×	4.6×-10.3×	14.9×-9.9×
Cash ratio	10×-0.5×	10.5×+6.4×	4.1×+1.3×	2.8×-17.3×
Leverage
Debt-to-equity	0×0.0×	0×—	——	——
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×—
Per Share
Book value per share	$4.16-86.2%	$30.12+108%	-$358.83-16,053%	-$2.22-127%
Valuation
Market capitalization	$184.2M+72.6%	$361.23M—	——	——
Enterprise value	-$7.49M-127%	$251.55M—	——	——
Price / book	1×-0.4×	3.5×—	——	——
Free cash flow yield	-27.5%+29.8pp	-14.2%—	——	——
Earnings yield	-31.8%+24.5pp	-14.6%—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do OnKure Therapeutics, Inc.'s ratios come from?: Every ratio is computed from OnKure Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.